Bourne Lent Asset Management Inc. grew its position in Symbotic Inc. (NASDAQ:SYM – Free Report) by 197.8% during the 1st quarter, HoldingsChannel reports. The fund owned 57,210 shares of the company’s stock after purchasing an additional 38,000 shares during the period. Symbotic comprises about 0.5% of Bourne Lent Asset Management Inc.’s investment portfolio, making the […]
Bourne Lent Asset Management Inc. cut its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 211,053 shares of the biopharmaceutical company’s stock after selling 600 shares during the period. […]
Bourne Lent Asset Management Inc. grew its holdings in Tesla, Inc. (NASDAQ:TSLA – Free Report) by 0.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 8,175 shares of the electric vehicle producer’s stock after acquiring an additional 75 shares during the […]
Bourne Lent Asset Management Inc. trimmed its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.2% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 3,976 shares of the company’s stock after selling 50 shares during the period. Eli Lilly and Company accounts for approximately […]
Bourne Lent Asset Management Inc. grew its holdings in Tesla, Inc. (NASDAQ:TSLA – Free Report) by 0.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 8,175 shares of the electric vehicle producer’s stock after acquiring an additional 75 shares during the […]